SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001640334-21-003250
Filing Date
2021-12-17
Accepted
2021-12-17 17:20:14
Documents
100

Document Format Files

Seq Description Document Type Size
1 POS AM lxrp_s1a.htm   iXBRL POS AM 1663858
2 EX-23.1 lxrp_ex231.htm EX-23.1 2988
8 lxrp_s1aimg9.jpg GRAPHIC 4782
9 lxrp_s1aimg10.jpg GRAPHIC 22529
10 lxrp_s1aimg7.jpg GRAPHIC 6208
11 lxrp_s1aimg8.jpg GRAPHIC 8493
  Complete submission text file 0001640334-21-003250.txt   7265084

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lexx-20210831.xsd EX-101.SCH 75589
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lexx-20210831_lab.xml EX-101.LAB 399725
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lexx-20210831_cal.xml EX-101.CAL 58343
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lexx-20210831_pre.xml EX-101.PRE 334056
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lexx-20210831_def.xml EX-101.DEF 172669
12 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_s1a_htm.xml XML 1258105
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: POS AM | Act: 33 | File No.: 333-250326 | Film No.: 211502693
SIC: 2834 Pharmaceutical Preparations